• A Nature review covers bio-inspired electronics: soft, biohybrid, and “living” neural interfaces. 1
  • The review directly informs next-generation invasive and chronic implants for neuroprosthetics and neural engineering. 1
  • It is tier-1 for device R&D and roadmap relevance. 1 1

Gardner updates

  • Emerging biohybrid neural interface technologies are being framed as futuristic options to bridge broken nerves and support neural repair or “mend minds” (New Scientist, September 2025). 2

Weekly enrichment (2026-07-20)

  • The underlying review is “Bio-inspired electronics: Soft, biohybrid, and ‘living’ neural interfaces” published in Nature Communications (vol. 16, article 1861, 21 February 2025), led by Dimitris Boufidis with corresponding authors D. Kacy Cullen and Flavia Vitale (University of Pennsylvania / Philadelphia VA Medical Center).3
  • It organizes bio-inspired neural interfaces into four categories along a continuum — biomimetic (tissue-matched soft materials), bioactive (biomolecule-functionalized coatings), biohybrid (cell-containing living layers), and all-living (devices composed solely of biological cells) — to combat the foreign body response (FBR).3
  • The central problem is mechanical mismatch: silicon has a Young’s modulus of ~180 GPa versus ~1–30 kPa for brain tissue, a roughly six-orders-of-magnitude gap that drives micromotion damage, glial scarring, rising electrode impedance, and signal loss in rigid arrays.3
  • Traditional clinical/research probes (DBS leads, Utah arrays, Michigan-style laminar probes, Neuropixels) rely on rigid platinum, gold, and silicon; the review traces alternatives such as mesh electronics, fibers, ultrathin films, elastomers, hydrogels, and conductive nanocomposites.3
  • Common flexible substrate/encapsulation polymers cited include PDMS, parylene-C, SU-8, polyimide (PI), and PET, with conducting polymers like PEDOT used to lower electrode impedance.3
  • A highlighted biomimetic device is the “e-dura” — a PDMS substrate with gold interconnects, Pt–PDMS composite electrodes, and a microfluidic drug-delivery channel matched to spinal dura mater elastic modulus — which restored locomotion in paralyzed rats via combined serotonergic drug delivery and electrical stimulation.3
  • Bioactive electrodes coated with ECM proteins (e.g., collagen I/fibronectin on Au–parylene-C arrays) promoted neurite outgrowth and reduced glial/microglial response at 2 mm cortical depth compared with bare silicon microelectrodes.3
  • For “all-living” interfaces, the review features micro-tissue-engineered neural networks (μTENNs) — neuronal aggregates in hydrogel microcolumns whose axonal tracts synaptically integrate with host tissue — including dopaminergic μTENNs aimed at reconstructing the nigrostriatal pathway in Parkinson’s disease models.3
  • Key translational challenges flagged are controlling cell fate, migration, and integration, and tuning secondary mechanisms (neurotransmitter release, microenvironment remodeling) to avoid off-target effects, increasing regulatory complexity relative to biomimetic devices built from clinically approved materials.3
  • The review situates these advances against the clinical BCI/BMI lineage (first human intracortical implant reported in 1998; BrainGate Utah-array trials in the early 2000s) and applications spanning ECoG epilepsy monitoring, responsive neurostimulation, speech decoding, and DBS.4

Footnotes

  1. https://news.google.com/rss/articles/CBMiX0FVX3lxTFB4LWJiZWVXV2lMOFNidHFrVnFIYnFZUGtSREcwX1BxVWo0SHNVcXk3eDFNZGJYbzRVbXNPXzM3dEhKc20wNGxfUFQ1SEFyZnFVZTBCWGVGdVJheEFiNmxF?oc=5 2 3 4

  2. https://news.google.com/rss/articles/CBMitwFBVV95cUxOa0lKMVVvTzI0UGxxM3NtT1dKNV9zUV81LWJKQTBnQnFlaWY3TkdZUG5qVlhreG9RVHBYTFJaVTlSX09KNkRzbUZJbFJ6YXAwLXV4SWNvMkRwQUs3bHU4eWVSLUVWYk9yVl9ZVE8ySUswbElEd3pnTXV6d1BSV0NEd2F3bG1LVGFVc1VmN3hDdW9Jd1lfZWdfVWxnM0IySEFOa3h5clhQdEhPVERyVWRTc21SYVVWWEk?oc=5

  3. https://www.nature.com/articles/s41467-025-57016-0 2 3 4 5 6 7 8 9

  4. https://pubmed.ncbi.nlm.nih.gov/39984447/